Article
Glutamate carboxypeptidase II (GCPII) genetic variants as determinants of hyperhomocysteinemia: implications in stroke susceptibility.
Indian journal of biochemistry & biophysics - 1 Oct 2012
Divyya Shree, Naushad Shaik Mohammad, Kaul Subhash, Anusha Vuppala, Subbarao Sreedhar Amere, Kutala Vijay Kumar
Abstract excerpt
The rationale of this case-control study is to ascertain whether glutamate carboxypeptidase II (GCPII) variants serve as determinants of hyperhomocysteinemia and contribute to the etiology of stroke. Hyperhomocysteinemia was observed in stroke cases compared to controls (14.09 +/- 7.62 micromol/L vs. 8.71 +/- 4.35, P < 0.0001). GCPII sequencing revealed two known variants (R190W and H475Y) and six novel variants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
